常州市存仁生物工程有限公司

Ambrisentan

Ambrisentan

Description of:Ambrisentan
Ambrisentan is an endothelin receptor type A-selective endothelin receptor antagonist. Ambrisentan is useful for pul...
更多>>
Sitaxsentan sodium

Sitaxsentan sodium

Description of:Sitaxsentan sodium
Sitaxsentan sodium (TBC11251 sodium salt) is an orally active, highly selective antagonist of endothelin A re...
更多>>
ARRY380

ARRY380

Description of:ARRY380
WZ3146 has a basic chemical framework (covalent pyrimidine) which is different from that of other EGFR inhibitors.This a...
更多>>
WZ3146

WZ3146

Description of:WZ3146
WZ3146 has a basic chemical framework (covalent pyrimidine) which is different from that of other EGFR inhibitors.This ag...
更多>>
WZ4002

WZ4002

Description of:WZ4002
WZ4002 has a basic chemical framework (covalent pyrimidine) which is different from that of other EGFR inhibitors. [1]
更多>>
WZ8040

WZ8040

Description of:WZ8040
WZ8040 is an irreversiblely inhibitor against EGFR T790M (mutation of the gatekeeper T790 residue) which is detected in 5...
更多>>
PF299804|达克替尼

PF299804|达克替尼

Description of:PF299804
PF299804 is a quinazalone-based irreversible pan-ERBB inhibitor structurally related to CI-1033. PF299804 is a potent i...
更多>>
PD153035

PD153035

Description of:PD153035
An extremely potent inhibitor of epidermal growth factor (EGF) receptor tyrosine kinase, with an IC50 of 25 pM. Inhibit...
更多>>
Pelitinib(EKB-569)|培利替尼

Pelitinib(EKB-569)|培利替尼

Description of:Pelitinib(EKB-569)
Pelitinib is a 3-cyanoquinoline pan-ErbB tyrosine kinase inhibitor with potential antineoplastic activity. Pe...
更多>>
来那替尼|Neratinib(HKI-272)

来那替尼|Neratinib(HKI-272)

Description of:Neratinib(HKI-272)来那替尼
Neratinib binds to the HER-2 receptor irreversibly, thereby reducing autophosphorylation in cells, appare...
更多>>
总数: 180 页: 16 / 18 首页 ←上一页 下一页→ 末页

在线联系

点击这里给我发消息